These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30530592)

  • 21. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
    Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
    Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB
    J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer.
    Zhu Y; Li M; Mu D; Kong L; Zhang J; Zhao F; Li Z; Liu X; Bo C; Yu J
    Oncotarget; 2016 Nov; 7(44):71455-71465. PubMed ID: 27683115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma.
    Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M
    Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
    Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
    Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
    Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
    J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.
    Toss MS; Abidi A; Lesche D; Joseph C; Mahale S; Saunders H; Kader T; Miligy IM; Green AR; Gorringe KL; Rakha EA
    Br J Cancer; 2020 May; 122(10):1496-1506. PubMed ID: 32203210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma.
    Al-Qahtani D; Anil S; Rajendran R
    J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
    Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
    Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density.
    Schnellhardt S; Hirneth J; Büttner-Herold M; Daniel C; Haderlein M; Hartmann A; Fietkau R; Distel L
    Front Immunol; 2022; 13():781222. PubMed ID: 35140715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.
    Han S; Zhang C; Li Q; Dong J; Liu Y; Huang Y; Jiang T; Wu A
    Br J Cancer; 2014 May; 110(10):2560-8. PubMed ID: 24691423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
    Koletsa T; Kotoula V; Koliou GA; Manousou K; Chrisafi S; Zagouri F; Sotiropoulou M; Pentheroudakis G; Papoudou-Bai A; Christodoulou C; Xepapadakis G; Zografos G; Petraki K; Pazarli E; Koutras A; Kourea HP; Bafaloukos D; Chatzopoulos K; Iliadis A; Markopoulos C; Venizelos V; Arnogiannaki N; Kalogeras KT; Kostopoulos I; Gogas H; Fountzilas G
    Cancer Immunol Immunother; 2020 Aug; 69(8):1549-1564. PubMed ID: 32303794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
    Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
    J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
    Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-infiltrating CD8
    Shimizu S; Hiratsuka H; Koike K; Tsuchihashi K; Sonoda T; Ogi K; Miyakawa A; Kobayashi J; Kaneko T; Igarashi T; Hasegawa T; Miyazaki A
    Cancer Med; 2019 Jan; 8(1):80-93. PubMed ID: 30600646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.
    Tímár J; Ladányi A; Forster-Horváth C; Lukits J; Döme B; Remenár E; Godény M; Kásler M; Bencsik B; Répássy G; Szabó G; Velich N; Suba Z; Elo J; Balatoni Z; Pócza K; Zemplén B; Chretien P; Talor E
    J Clin Oncol; 2005 May; 23(15):3421-32. PubMed ID: 15908653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
    Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
    Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.